Ziphius is a self-amplifying RNA company developing vaccines for infectious diseases and gene supplementation therapies, aiming to create a new generation of medical tools.
Our Pipeline
Z009
Chlamydia trachomatis
Program
Indication
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Z009
Chlamydia trachomatis
Z010
Pan Corona
Program
Indication
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Z010
Pan Corona
Z005
Cystic Fibrosis
Program
Indication
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Z005
Cystic Fibrosis
Z008
Oncology
Program
Indication
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Z008
Oncology

In an increasingly digital world, expectations around speed and convenience are higher than ever. People are used to instant messaging, same-day deliveries, and streaming without buffering — so why should online gaming be any different? Today’s players no longer tolerate delays when it comes to accessing their winnings. They want a streamlined, frictionless experience from start to finish. Choosing platforms that understand this need is essential for those who treat gaming seriously. Whether through e-wallets, crypto transfers, or traditional methods, the best services now provide near-immediate access to funds. That’s why many players specifically search for fast payout casinos that offer guaranteed speed without compromising security. These aren’t just conveniences — they’re trust factors. A platform that honors withdrawals quickly shows it values player satisfaction, reliability, and operational integrity. In a saturated market, this one feature can make all the difference when deciding where to play again.
Partnering
Product Partnering
Partnerships with Ziphius can be made to develop LNP-encapsulated sa-RNA-based therapeutics through out-licensing or risk-sharing models.
Technology Partnering
Ziphius seeks collaborations to explore its various platform technologies in various disease areas.